Retained by Robbins Geller
Dr. Andrew Zuppann of Vega Economics was retained by a group of pension funds as opt-out plaintiffs in a securities case to analyze issues related to a pharmaceutical company's alleged price fixing and market allocation scheme for certain generic drugs.